Delivered chemotherapy
ADVERSE EVENTS, PERIPHERAL SENSORY NEUROPATHY
The median number of treatment cycles was 6 (range: 1–38). One‐stage dose reduction occurred in four patients, and two‐stage dose reduction occurred in four. Two‐stage dose reductions were due to a decline in neutrophil count and peripheral sensory neuropathy. Four patients could not continue treatment because of adverse events, and two could not continue because of patient refusal.